Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level

被引:309
|
作者
Kmiecik, Justyna [1 ]
Poli, Aurelie [1 ]
Brons, Nicolaas H. C.
Waha, Andreas [2 ]
Eide, Geir Egil [3 ,4 ]
Enger, Per Oyvind [5 ]
Zimmer, Jacques
Chekenya, Martha [1 ,6 ]
机构
[1] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway
[2] Univ Hosp, Dept Neuropathol, Bonn, Germany
[3] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway
[4] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway
[5] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway
[6] Univ Bergen, Dept Clin Dent, N-5009 Bergen, Norway
关键词
GBM; Tumor infiltrating cells; Regulatory T cells; Antigen presenting cells; REGULATORY T-CELLS; MGMT PROMOTER METHYLATION; NATURAL-KILLER-CELLS; NK CELLS; ADJUVANT TEMOZOLOMIDE; PROGNOSTIC VALUE; RECEPTOR; CANCER; EXPRESSION; NKG2D;
D O I
10.1016/j.jneuroim.2013.08.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We characterized GBM patients' tumor and systemic immune contexture with aim to reveal the mechanisms of immunological escape, their impact on patient outcome, and identify targets for immunotherapy. Increased CD3 T-cell infiltration was associated with prolonged survival independent of age, MGMT promoter methylation and post-operative treatment that implies potential for immunotherapy for GBM. Several mechanisms of escape were identified: within the tumor microenvironment: induced cD8+cD28 Foxp3 Tre that may tolerize antigen presenting cells, elevated CD73 and CD39 ectonucleotidases that suppress T-cell function, and at the systemic level: elevated IL-10 levels in serum, diminished helper T-cell counts, and upregulated inhibitory CTLA-4. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:71 / 83
页数:13
相关论文
共 50 条
  • [21] Tumor-infiltrating CD36+CD8+T cells determine exhausted tumor microenvironment and correlate with inferior response to chemotherapy in non-small cell lung cancer
    Ao, Yong-Qiang
    Gao, Jian
    Zhang, Ling-Xian
    Deng, Jie
    Wang, Shuai
    Lin, Miao
    Wang, Hai-Kun
    Ding, Jian-Yong
    Jiang, Jia-Hao
    BMC CANCER, 2023, 23 (01)
  • [22] Combined blockade of TGF-β and PD-1 restores the function of tumor-infiltrating CD8+ T cells in glioblastoma
    Kim, A. R.
    Park, J.
    Kang, S-G.
    Moon, J. H.
    Kim, E. H.
    Park, S-H.
    Chang, J. H.
    Shin, E-C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1733 - 1733
  • [23] Tumor-infiltrating CD36+CD8+T cells determine exhausted tumor microenvironment and correlate with inferior response to chemotherapy in non-small cell lung cancer
    Yong-Qiang Ao
    Jian Gao
    Ling-Xian Zhang
    Jie Deng
    Shuai Wang
    Miao Lin
    Hai-Kun Wang
    Jian-Yong Ding
    Jia-Hao Jiang
    BMC Cancer, 23
  • [24] Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer
    Liikanen, Ilkka
    Basnet, Saru
    Quixabeira, Dafne C. A.
    Taipale, Kristian
    Hemminki, Otto
    Oksanen, Minna
    Kankainen, Matti
    Juhila, Juuso
    Kanerva, Anna
    Joensuu, Timo
    Tahtinen, Siri
    Hemminki, Akseli
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [25] CD8+ tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival
    Millen, Rosemary
    Hendry, Shona
    Narasimhan, Vignesh
    Abbott, Rebecca
    Croxford, Matthew
    Gibbs, Peter
    Tie, Jeanne
    Wong, Hui-Li
    Jones, Ian
    Kosmider, Suzanne
    Byrne, David
    Zalcberg, John
    Fox, Stephen
    Desai, Jayesh
    Visvanathan, Kumar
    Ramsay, Robert G.
    Tran, Ben
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (07)
  • [26] Tumor-infiltrating CD8+ T cells in ALK-positive lung cancer are functionally impaired despite the absence of PD-L1 on tumor cells
    Zeng, Chenxi
    Gao, Yi
    Xiong, Jing
    Lu, Jiawei
    Yang, Jianjian
    Wang, Xue
    Cai, Yixin
    Li, Lequn
    Fu, Xiangning
    LUNG CANCER, 2020, 150 : 139 - 144
  • [27] Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
    Kitamura, Takanori
    Doughty-Shenton, Dahlia
    Pollard, Jeffrey W.
    Carragher, Neil O.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (143):
  • [28] Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
    Kim, Hyung-Don
    Song, Gi-Won
    Park, Seongyeol
    Jung, Min Kyung
    Kim, Min Hwan
    Kang, Hyo Jeong
    Yoo, Changhoon
    Yi, Kijong
    Kim, Kyung Hwan
    Eo, Sukyeong
    Moon, Deok-Bog
    Hong, Seung-Mo
    Ju, Young Seok
    Shin, Eui-Cheol
    Hwang, Shin
    Park, Su-Hyung
    GASTROENTEROLOGY, 2018, 155 (06) : 1936 - +
  • [29] CD8+ tumor-infiltrating lymphocytes as a statistically significant marker of disease recurrence and survival in transitional cell carcinoma patients.
    Sharma, P.
    Sato, E.
    Bajorin, D.
    Shen, Y.
    Wen, S.
    Reuter, V.
    Jungbluth, A.
    Gnjatic, S.
    Old, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 227S - 227S
  • [30] A Pro-Inflammatory Tumor Microenvironment with High Chemokine Expression and High Tumor-Infiltrating CD3+CD8+Numbers Associates with Improved Survival in Ewing Sarcoma (EWS)
    Berghuis, D.
    Santos, S. J.
    Baelde, J. J.
    Taminiau, A. H. M.
    Egeler, R. M.
    Schilham, M. W.
    Hogendoorn, P. C. W.
    Lankester, A. C.
    LABORATORY INVESTIGATION, 2010, 90 : 15A - 15A